Le Lézard
Classified in: Health
Subjects: CHI, SVY, DEI

Momentum Health receives FDA 510K Clearance for Momentum Spine, a Pioneering AI-Enabled Mobile Application for Monitoring Scoliosis, Available for Download Now!


After receiving their Health Canada class 1 medical device clearance, Momentum Spine continues to gain traction with FDA clearance and the launch of their mobile app. 

MONTREAL, Feb. 15, 2024 /CNW/ - Momentum Health Inc. is excited to announce that its innovative mobile application, Momentum Spine, has received U.S. Food and Drug Administration (FDA) clearance. This state-of-the-art AI application offers a non-invasive, radiation-free solution to quantify postural asymmetries, including scoliosis, directly targeting a long-standing challenge in managing spinal deformities.

DOWNLOAD NOW ON THE APP STORE (HERE) OR THE GOOGLE PLAY STORE (HERE)

Scoliosis is the most prevalent spine deformity affecting 3% of Children 1 and an estimated 68% of adults above 60 years old 2. It is defined as a sideways curvature of the spine in the coronal plane. The key to successful scoliosis management is early detection and frequent monitoring. However, in our current standard of care scoliosis patients are at elevated risks of cancer due to repetitive radiation exposure via X-Rays 3.

Momentum Spine is an AI-enabled digital health platform to remotely monitor postural asymmetries, including scoliosis, using a simple video taken on a smartphone. The platform can be used by clinicians and care teams to remotely monitor scoliosis patients with less radiation exposure and more continuous follow-up as well as the general population who would like to monitor their spine health.

LEARN MORE ABOUT MOMENTUM SPINE

With the recent FDA clearance, Momentum Health is progressing to the commercialization phase for the Momentum Spine technology. The company will offer their solution to health systems through institutional licenses and also make it available directly to consumers via app stores.

Key features and benefits of Momentum Spine include:

Dr. Jean Ouellet, a Pediatric Spine Surgeon and the Chief Medical Officer of Momentum Health Inc., shared his enthusiasm: "Receiving FDA clearance is a monumental achievement for Momentum Health. Momentum Spine not only empowers patients and healthcare providers with accurate and timely data but also signifies a leap in harnessing AI for spine care."

Try it for yourself TODAY!

**Indications for Use:**

The Momentum Spine app is an optical contour sensing mobile application intended to quantify asymmetries, assess body angles, and track curve progression related to postural asymmetries, including scoliosis. The application is available directly to lay users (Over-the-Counter) and may also be prescribed by physicians. It is designed for patients aged 8 years and older.

About Momentum Health Inc.:

Momentum Health Inc., based in Montreal, QC, is committed to creating groundbreaking digital health solutions that enhance patient care, optimize healthcare resources and empower individuals to quarterback their health.

References:

1- Mo, Fred, and Matthew E Cunningham. "Pediatric scoliosis." Current reviews in musculoskeletal medicine vol. 4,4 (2011): 175-82. doi:10.1007/s12178-011-9100-0


2- Konieczny, Markus Rafael et al. "Epidemiology of adolescent idiopathic scoliosis." Journal of children's orthopaedics vol. 7,1 (2013): 3-9. doi:10.1007/s11832-012-0457-4


3- Loughenbury, P. R., et al. "Estimated cumulative X-ray exposure and additional cancer risk during the evaluation and treatment of scoliosis in children and young people requiring surgery." Spine Deformity 9 (2021): 949-954. doi:10.1007/s43390-021-00314-6

 

SOURCE Momentum Health Inc.


These press releases may also interest you

at 09:15
Acadia Pharmaceuticals Inc. today announced the launch of Magnolia's Guide to Adventuring, a new, 10-part, documentary video series by award-winning TV producer, AJ Tesler, and his wife, Jenny Tesler, featuring their 13-year-old daughter, Magnolia,...

at 09:00
Anonybit announced today a significant upgrade to its Decentralized Data Vault offering, enabling support for an expanded range of use cases across the identity management lifecycle. The Anonybit Decentralized Data Vault builds upon the company's...

at 09:00
Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCstm), today announced the appointment of Simona Skerjanec, M.Pharm, MBA to its board of...

at 09:00
Agreement with FDA reached on key elements to move forward with our international Phase 3 clinical trial programAgreement also reached with FDA on complete non-clinical and clinical development plan for filing of a New Drug Application for marketing...

at 09:00
Mural Health, a patient-first clinical trial technology company, was named "Most Innovative Start-up" at the 2024 Citeline Awards. Hosted by Citeline (a leading provider of business intelligence in the pharmaceutical and medtech markets), this award...

at 09:00
Inimmune, a leading clinical stage biotech company focused on the development of novel vaccine adjuvants, immunotherapies and delivery systems, announced today the top line results from its Phase 1b Multiple Ascending Dose (MAD) study of INI-2004 in...



News published on and distributed by: